Overview
- 59 inspections across 57 sites are on record.
- 99 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2013-11-05.
At a glance
Inspections
59
Sites
57
Observations
99
Career since
Dec 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Newark Beth Israel Med Ctr IRB | 5 Nov 2013 | Human Drugs | View 483 → |
| Roberto Giugliani, MD, PhD | 2 Aug 2013 | Human Drugs | |
| Nelson Rassi, M.D., Principal Investigator | 26 Jul 2013 | Human Drugs | View 483 → |
| Prof. Johnny Mahlangu | 18 Jul 2013 | Biologics | View 483 → |
| Merck Sharp & Dohme | 13 Jun 2013 | Human Drugs |
Sites inspected
Newark Beth Israel Med Ctr IRBNewark, United States1 insp.
Roberto Giugliani, MD, PhDPorto Alegre, Brazil1 insp.
Nelson Rassi, M.D., Principal InvestigatorGoiana, Brazil1 insp.
Prof. Johnny MahlanguJohannesburg, South Africa1 insp.
Merck Sharp & DohmeSummit, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Peter R Lenahan4 shared
Kelly Doremus4 shared
Jonee J Mearns3 shared
Christina N Maurino3 shared
Valerie C Reed2 shared
Sherri J Liu2 shared
Melissa B Libby2 shared
Tressa T Lewis2 shared
Cary Greene1 shared
Michael Serrano1 shared
Full investigator report
Get the verbatim findings behind Krystal O Ogunremi's 99 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site